RESEARCH

SC BIO Personalized Medicine Day Registration

FOR IMMEDIATE RELEASE

Media Contact:
Amy Bomar
Bomar Marketing Solutions for SCBIO
(864) 306-7703
amy@bomarmarketingsolutions.com

 “Personalized Medicine Awareness Day” focuses on “revolution”  toward gene-based individualized health care

Greenville, SC—October 3, 2012— What has been called a revolution of health care from “trial-and-error, one-size-fits-all” medicine to the use of gene-based therapies that target specific characteristics in an individual or disease is the topic of Personalized Medicine Awareness Day for health care professionals, 5-8 p.m. Tuesday, November 13 at the Hyatt Hotel in Greenville.

World renown molecular biologist Leroy Hood, who helped develop the automated gene sequencer and now is a leading advocate for personalized medicine will give a short presentation, followed by discussion of a panel of experts.

Hood has called the increasing use of gene-based therapies a “revolution” that will bring down the cost of health care in 10 years and overhaul the current business models of health care.

“Personalized Medicine Awareness Day events are being hosted across the country because the field is advancing so fast, many health care professionals do not know all the developing uses of gene-based information,” said Wayne Roper, president of the South Carolina Biotechnology Industry Organization (SCBIO), a sponsor of the event.

Personalized Medicine Awareness Day is part of SCBIO’s  “What Next?” annual conference in November. The event will bring together health professionals and researchers to discuss the significantly emerging development of clinical genomics and “precision medicine.”

Along with SCBIO, the event is sponsored by Bon Secours St. Francis Health System, Gibbs Cancer Center, Greenwood Genetic Center, Iverson Genetics, Lilly USA, and Pfizer.

“Gibbs Cancer Center is committed to embracing this rapidly advancing aspect of medicine,” said James Bearden, MD, vice president of research for Spartanburg Regional Healthcare System and managing physician of Gibbs Cancer Center.

“Already, new genomic tests continued to be created at a rapid pace as scientists learn more about the genomic and molecular structures of disease and therapeutic responses. Personalized medicine will enable us to provide better diagnoses, safer prescription practices and more effective clinical care.” 

The Greenwood Genetic Center has been making progress for over 38 years in increasing the knowledge of the role of genetics and environment in causing birth defects and intellectual disabilities, said Dr. Steve Skinner, senior clinical geneticist and director.

“We have also been providing educational opportunities such as the mobile science laboratory and school programs to raise the awareness of the advances in medical genetics.”

Gene-based Prescriptions

“Genetic-based prescriptions are reducing adverse reactions, improving outcomes and often lowering costs from the current ‘trial-and-error’ approaches,” said Dean Sproles, CEO of Iverson Genetics.

The Personalized Medicine Coalition released these facts:

  • 34 percent of radiation chemotherapy would not be necessary if women with breast cancer receive a genetic test prior to treatment
  • 17,000 strokes could be prevented each year with a genetic test to correctly dose the blood thinner warfarin
  • 10 percent of marketed drugs inform or recommend genetic testing for optimal treatment
  • 33 pharmacogenomic biomarkers are included on FDA-approved drug labels 
  • 72 gene based therapies are now approved, compared to 13 in 2006

The Greenville Hospital System and its Institute for Translational Oncology (ITOR) has been focusing on advancing patient care through personalized medicine and translational research that can lead to groundbreaking treatments, said Sam Konduros, ITOR business development director.

“ That focus is clearly evidenced by our commitment and desire to bring molecular medicine to the clinic through innovative initiatives such as the Lab21 Clinical Genomics Center at ITOR-GHS, “ he said.

Personalized Medicine Awareness Day will include a reception with light hors d’oeuvres, a presentation by Dr. Hood and a panel discussion featuring experts from the Medical University of South Carolina, Gibbs Cancer Center and Research Institute, Iverson Genetics, the Greenwood Genetic Center and the Institute of for Transitional Oncology Research of the Greenville Hospital System on how clinical genomics is changing the standards of care. The Greenwood Genetic Center’s Gene Machine, a 41-foot custom bus equipped as a state-of-the-art genetics laboratory will also be available for tours and demonstrations.

Registration for Personalized Medicine Day is available at www.scbio.org.  The cost is $12 for non-SCBIO members and $8 for members. Registration is also available for SCBIO’s “What Next?” conference, an event that will bring leaders in biotech and healthcare to the state to drive discussions on growing South Carolina’s life sciences economy.

About SCBIO

The South Carolina Biotechnology Industry Organization (SCBIO) is a statewide member-driven organization that advances life science business and innovation through collaboration, advocacy, workforce development and support. South Carolina life sciences businesses and industries grew 45 percent more jobs and added another 23 percent more businesses for nearly 15,000 total employment between 2001 and 2010, according to a 2012 Battelle Institute and Biotechnology Industry Organization (BIO) report.  The average annual South Carolina wage in life sciences is $55,233. One sector, Medical Devices and Equipment, employs 4,226 across 76 companies.

SCBIO represents a broad array of bio businesses that are innovating: pharmaceuticals, vaccines, medical devices, medical equipment, agricultural bio and biofuels.  SCBIO has offices in Greenville, Columbia and Charleston. For more information, visit www.scbio.org.

 
 
 

© 2012  Medical University of South Carolina | Disclaimer